BBLG

NASD Bone Biologics Corp.

Nov 6, 2026 · 2:13 AM ET EOD Market Closed

$0.3237 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.3237, $0.0243 below the day’s high of $0.3480

YTD change: -77.68%
vs 20-day SMA: -19.64%
vs 200-day SMA: -68.90%

Price ranges

Previous day

$0.3469 $0.3799

open $0.3780 close $0.3471

-$0.0309 (-8.17%)

Today

$0.3224 $0.3480

open $0.3480 now $0.3237

-$0.0243 (-6.98%)

Past week

$0.3469 $0.4100

from $0.3920 now $0.3237

-$0.0683 (-17.42%)

Past month

$0.3469 $0.4922

from $0.4875 now $0.3237

-$0.1638 (-33.60%)

This year

$0.3224 $1.8845

from $1.4500 now $0.3237

-$1.1263 (-77.68%)

Price & Performance

-1.00 (-75.48%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor

The stock is 100.0% away from all-time highs of $10,255.5000
BBLG is down 78% since the beginning of the year
BBLG is down 84% over the past 12 months
BBLG is down 34% over the past 1 month
1% of all BBLG investors are betting against BBLG

BBLG reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -83.9%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No

EPS $-0.43

Earnings momentum -152.9% Quarterly EPS growth

Quarterly change -152.9%

Valuation

P/E ratio N/A

Enterprise value $-3408130.0

Beta 1.75

Balance sheet & scale

IncomeN/A

RevenueN/A

Cash$4.0M

DebtN/A

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Professional, Scientific, and Technical Services

Industry Group Scientific Research and Development Services

Market cap $1.3M

Bone Biologics Corp. operates as a medical device company. It engages in the research and development of bone regeneration in spinal fusion. The firm's core product is NELL-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. Its platform technology has application in delivering improved outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA.

Competitor comparison

Ticker	Company	Price	Change
AMGN	Amgen Inc.	$460.28	-3.80%
MRNA	Moderna, Inc.	$241.46	-6.55%
RVMD	Revolution Medicines, Inc.	$177.65	-11.04%
ROIV	Roivant Sciences Ltd.	$36.62	-4.21%
BNTX	BioNTech SE Sponsored ADR	$85.86	-5.34%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.